Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06082648

Study of Brain-Gut Function Reconstruction After Intersphincteric Resection for Ultra-Low Rectal Tumors

To investigate the effects of intersphincteric resection (ISR) of ultra-low rectal tumor on the brain-rectoanal function of patients, and to precisely localize the cerebral functional regulatory regions for intervention targets of anorectal remodeling. Utilizing transcranial magnetic stimulation(TMS) technology to explore the functional remodeling of the "new" anorectal muscle groups and provide a theoretical basis for more research on the rehabilitation and mechanism of fecal incontinence.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This study is a Single-center Phase II, Open, Three-Arm clinical trial. We prospectively enroll patients who undergo ISR for ultra-low rectal tumor in the department of General Surgery, Huashan Hospital, Fudan University. Patients with ileostomy closure are randomly divided into two groups (TMS group and false stimulation group), and healthy volunteers were recruited. The differences of task-state fMRI between healthy volunteers, and ISR patients (both preoperative and postoperative) are compared, combined with rectal function scores (Wexner score, LARS score) and quality of life scale (EORTC QLQ-C30, EORTC QLQ-CR38). Proctoanal manometry are used to find the precise location of the proctoanal motor function area in the cerebral cortex, and to evaluate the effect and value of TMS on postoperative anorectal motor function remodeling in patients with ISR.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Primary ultra-low rectal tumor patient who is received intersphincteric resection and preventive ileostomy was performed.
  • Patient who is willing to participate in the study, and voluntarily sign informed consent.

Exclusion criteria

  • Anastomotic leakage or other serious complications occur after surgery.
  • Advanced tumor, tumor recurrence or metastasis.
  • Patients with contraindications of fMRI scanning, such as history of metal implants in the body, claustrophobia, etc.
  • Patients with contraindications for TMS treatment, such as intracranial metal implants, epilepsy history, heart disease with unstable heart function, retinal detachment, etc.
  • Combined with organic brain disease and drug abuse history.
  • Combined with other mental diseases.
  • Pregnant or lactating women.

Treatment and study plan

Transcranial Magnetic Stimulation

Device

The magnetic stimulator equipment is provided by the MagProX100 magnetic stimulator ( MagVenture, Lucernemarken, DK-3520 Farum, Denmark), with 8-shaped coil, a maximum stimulation frequency of 30Hz and a maximum stimulation intensity of 6 Tesla.Stimulation group: Intermittentpulse transcranial magnetic stimulation (iTBS) will be performed with : the cluster consists of 3 pulses, the intra-cluster frequency is 50Hz, the intercluster frequency is 5Hz, the interval is 8.2s for every stimulus. There are 20 cycles and a total of 600 pulses. Each intervention time is 3min11s, and the stimulation intensity is set as 80% resting state motion threshold. The intervention will be performed once a day for 2 weeks.

Sham Transcranial magnetic stimulationt

Device

The magnetic stimulator equipment is provided by the MagProX100 magnetic stimulator ( MagVenture, Lucernemarken, DK-3520 Farum, Denmark), with 8-shaped coil, a maximum stimulation frequency of 30Hz and a maximum stimulation intensity of 6 Tesla. Patients on the Sham stimulation group will be interfered with the stimulation coil perpendicular to the skull, so that they will hear the sound of machine without having therapeutic effects. The parameters will be the same as those in the stimulation group.

Primary outcomes

  1. The differences of cortical activated areas in task-state fMRI in ISR patients.

    Time frame: pre-ISR, pre-ileostomy closure, 6,12 month after ileostomy closure.

    Cortical activated areas in BOLD sequence of patients in different time frame

  2. The differences of cortical activated areas in task-state fMRI between health volunteers and postoperative ISR patients.

    Time frame: 12 month after ileostomy closure。

    Cortical activated areas in BOLD sequence of health volunteers and patients

  3. Rectal function scores (Wexner score)

    Time frame: pre-ISR,1, 3 , 6, 9, 12, 18, 24 month after ileostomy closure.

    Wexner score of patients in different time frame

  4. Rectal function scores (LARS score)

    Time frame: pre-ISR,1, 3 , 6, 9, 12, 18, 24 month after ileostomy closure.

    LARS score of patients in different time frame

  5. Quality of life Scale (EORTC QLQ-C30)

    Time frame: pre-ISR,1, 3 , 6, 9, 12, 18, 24 month after ileostomy closure.

    EORTC QLQ-C30 of patients in different time frame

  6. Quality of life Scale (EORTC QLQ-CR38)

    Time frame: pre-ISR,1, 3 , 6, 9, 12, 18, 24 month after ileostomy closure.

    EORTC QLQ-CR38 of patients in different time frame

Secondary outcomes

  1. Proctoanal manometry

    Time frame: pre-ISR,3 , 6, 12, 18, 24 month after ileostomy closure.

    Proctoanal manometry of Patients in different time frame

Study contacts

Contact information is provided by the study sponsor or research team.

Ying Mao, PhD

CONTACT

[email protected]

8621-52889999

Sponsors and collaborators

Lead sponsor

Huashan Hospital

Other

Registry information

Official study title

Observation and Intervention Study of Brain-Gut Function Reconstruction After Intersphincteric Resection (ISR) for Ultra-Low Rectal Tumors

Important dates

Study start
2023
Primary completion
2024
Study completion
2026
First posted
Oct 13, 2023
Registry last updated
Oct 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.